Mark Blotcky
Psychiatry · Dallas, TXNPI 1023123148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations.
Across 198 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$426
- Otsuka America Pharmaceutical, Inc.$339
- Lundbeck LLC$329
- Bausch Health US, LLC$285
- Johnson & Johnson$256
- Takeda Pharmaceuticals U.S.A., Inc.$252
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,485100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $426 |
| Otsuka America Pharmaceutical, Inc. | 17 | $339 |
| Lundbeck LLC | 18 | $329 |
| Bausch Health US, LLC | 23 | $285 |
| Johnson & Johnson | 15 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $252 |
| Vanda Pharmaceuticals Inc. | 8 | $224 |
| Alkermes, Inc. | 11 | $203 |
| Tris Pharma Inc | 10 | $189 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $178 |
| Sunovion Pharmaceuticals Inc. | 13 | $173 |
| Shire North American Group Inc | 7 | $136 |
| Avanir Pharmaceuticals, Inc. | 6 | $106 |
| Corium, LLC | 2 | $64 |
| Neos Therapeutics, LP | 3 | $54 |
| Merck | 3 | $50 |
| Neurocrine Biosciences, Inc. | 2 | $49 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Adlon Therapeutics L.p. | 1 | $26 |
| Noven Therapeutics, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,489 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.